Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by quest13on Apr 15, 2013 4:25pm
337 Views
Post# 21256500

the news release is clear to me

the news release is clear to me

I fail to understand the complaints of Drill and Micanwait I have no problem with the companies news release.

Even Don's reply to the question of the USA holders was correct even though it raised questions - you have to be shareholders of RVX to be part of the spinout. It turns out that the USA holders are holders of RVX even though their brokers call it RVXCF it is still the same stock.

As far as the "record date" is concerned it is common usage that only those on record as of that date are entitled to vote. That is no problem as far as I am concerned.

As far as "meeting date" is concerned it is clearly the date on which the meeting will be held - that is no problem as far as I am concerned even though that date may change to the official "set in stone date" when the official papers come out I see that as being set when management and the board have finished the paperwork.

As far as the "effective date" is concerned see my above comments regarding the other dates.

as far as the warrants are concerned I believe that it is quite clear in the news release.

"Every Resverlogix warrant holder at the effective date will receive one warrant in Spinco for every warrant held in Resverlogix. The exercise price of Resverlogix warrants would be reduced in accordance with the terms of the applicable warrant by an amount on a per share basis to reflect the fair market value of Spinco and the reduction would be allocated to the exercise price of the replacement Spinco warrants. If a Resverlogix warrant holder wishes to participate in the Arrangement and receive common shares of Spinco at the effective date, the warrant holder will need to exercise their Resverlogix warrants prior to the effective date of the Arrangement to acquire Resverlogix common shares."

This clearly says to me that if you have RVX stock (even RVXCF which is stock in RVX) at the effective date then you receive stock in Spinco.

If you have a warrant for RVX  then you can receive a warrant for Spinco, and the price for each of your warrants (RVX and Spinco) is reset so that the original warrant price is now reflected in total among the now two warrants being one for Spinco and  the original RVX at the new price. If you would prefer to receive stock rather than a warrant in Spinco then you would have to exercise your warrant to hold a share in RVX prior to the effective date. I cannot see any benefit to doing so.

I in particular want the warrants since I need not put more cash down and will have the right to buy later at the set price. I see myself buying when a deal is done for the sale and not prior to a deal.

I also see the sale at the negotiated price being my ability to sell my shares to the buyer for a clear capital gain, with the tax benefits on Capital gains.

I do not see anything to complain about and in particular complaining to the SEC and OSC which is called for in the message “time to call the sec and osc is not in any way justified.  

Bullboard Posts